Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

44
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
44
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

34
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
34
Obesity01:24

Obesity

785
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
785
Anatomy of the Intestines01:23

Anatomy of the Intestines

84.4K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
84.4K
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

774
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
774
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

33
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
33

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Mechanism of Quzhou Aurantii Fructus in treating rats with functional dyspepsia based on gut microbiota and metabolomics].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026
Same author

Author Correction: ID1 expressing macrophages support cancer cell stemness and limit CD8<sup>+</sup> T cell infiltration in colorectal cancer.

Nature communications·2026
Same author

Ai-Fen Solid Dispersions: Preparation, Characterization, and Enhanced Therapeutic Efficacy in a Rat Model of Oral Ulceration.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Metabolomic analysis of microbial effects on quality and metabolite conversion in rapidly fermented salt-free shrimp by-product sauce.

Food chemistry: X·2025
Same author

<i>HOXD-AS1</i> interacting with AMPK causes a disturbance in mTOR signaling, impairing ferroptosis in glioma.

Biochemistry and cell biology = Biochimie et biologie cellulaire·2025
Same author

High-efficiency chemiluminescent POCT assay for anti-Müllerian hormone: innovative development and application in polycystic ovary syndrome diagnosis.

Analytical methods : advancing methods and applications·2025

Related Experiment Video

Updated: Oct 26, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

30.5K

Gut microbiota in obesity.

Bing-Nan Liu1, Xiao-Tong Liu1, Zi-Han Liang1

  • 1School of Bioengineering, Dalian Polytechnic University, Dalian 116034, Liaoning Province, China.

World Journal of Gastroenterology
|July 29, 2021
PubMed
Summary
This summary is machine-generated.

Obesity is a growing global health issue linked to gut microbiota. Understanding these complex interactions is key to developing new obesity treatments through gut microbiota management.

Keywords:
DysbiosisEcologyGeneticsGut microbiotaObesity

More Related Videos

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

9.8K
Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

4.6K

Related Experiment Videos

Last Updated: Oct 26, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

30.5K
An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

9.8K
Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

4.6K

Area of Science:

  • Microbiology
  • Genetics
  • Public Health

Background:

  • Obesity is a significant and increasing global health concern.
  • Emerging evidence highlights a strong connection between obesity and the gut microbiota.
  • Gut microbiota modulation is a novel therapeutic strategy for obesity.

Purpose of the Study:

  • To review the characteristics of gut microbiota in obesity.
  • To elucidate the mechanisms by which gut microbiota induces obesity.
  • To explore the influence of genetic and environmental factors on gut microbiota and obesity.

Main Methods:

  • Literature review of existing studies on obesity and gut microbiota.
  • Analysis of mechanisms linking gut microbiota composition to obesity.
  • Synthesis of data on genetic and environmental impacts.

Main Results:

  • Gut microbiota composition differs significantly in obese individuals.
  • Specific microbial pathways are implicated in obesity development.
  • Host genetics and environmental factors modulate gut microbiota and obesity risk.

Conclusions:

  • The gut microbiota plays a crucial role in obesity.
  • Further research into the complex interplay of genetics, environment, and microbiota is needed.
  • Targeting the gut microbiota holds promise for future obesity interventions.